Connect with us

News

Self-guided hypnosis significantly reduces menopausal hot flushes, study finds

Published

on

Daily self-guided hypnosis cut hot flushes by over 50 per cent in postmenopausal women, a new clinical trial has found.

The multicentre randomised clinical trial tested a six-week, self-administered hypnosis programme against a sham control using white noise.

It enrolled 250 postmenopausal women with frequent hot flushes — sudden heat surges that can disrupt sleep and daily life.

Nearly 25 per cent of participants had a history of breast cancer, a group often unable to use hormone therapies because of safety concerns.

Lead researcher Gary R. Elkins, professor of psychology and neuroscience and director of the Mind-Body Medicine Research Laboratory at Baylor, said the findings offer hope for women seeking non-hormonal options.

Elkins said: “It is estimated that over 25 million women in the United States have hot flushes, with up to 80 per cent of women in the general population reporting hot flushes during the menopause transition, and 96 per cent of women with breast cancer report hot flushes soon after beginning anti-cancer therapy.

He added: “While hormone replacement therapy is highly effective in reducing hot flushes, it is not a safe choice for everyone, and therefore, women need additional safe and effective alternatives.”

After six weeks of daily self-hypnosis audio recordings, participants reported a 53.4 per cent reduction in both frequency and intensity of hot flushes. At the three-month follow-up, hot flushes were reduced by 60.9 per cent, compared with 40.9 per cent for the control group.

Women with a history of breast cancer saw a 64 per cent reduction after six weeks.

The trial is the first to compare self-guided hypnosis with an active control, helping to separate treatment effects from expectancy or the placebo effect — improvement driven by belief rather than the intervention itself.

Elkins said: “This was a major breakthrough and innovation, as almost all prior studies of mind-body interventions have only used wait-list, psycho-education or simple relaxation to compare the active hypnotherapy intervention.”

He added: “Also, all sessions were self-administered hypnosis, which demonstrated that women could learn how to use hypnosis for hot flushes on their own with support and guidance.

“It can be practised at home without needing to travel for doctor visits, and it is relatively inexpensive compared to in-person sessions.

“Once a person learns how to use self-hypnosis to reduce hot flushes and improve sleep, it can be used for other purposes such as managing anxiety, coping with pain and for stress management.”

At 12 weeks, the hypnosis group showed greater gains in sleep, mood, concentration and quality of life. Nearly 90 per cent reported feeling better, versus 64 per cent in the control arm.

Elkins said: “We are very excited about the findings from this important study.

He added: “Our ongoing research aims to further determine how self-hypnosis can significantly improve sleep for breast cancer survivors and women in the peri- to post-menopause transition.”

Through this and other studies, Elkins and colleagues say hypnotherapy is the only behavioural intervention consistently shown to reduce hot flush frequency and severity to a clinically significant level in postmenopausal women and breast cancer survivors.

Diagnosis

Researchers develop nasal therapeutic HPV vaccine

Published

on

Researchers have created a therapeutic HPV vaccine delivered through the nose that could offer a non-invasive treatment for cervical cancer.

Screening for HPV and preventive vaccines lower risk, but there are no approved therapies for existing HPV infections or HPV-linked cancers.

Current treatments include surgery, radiotherapy and chemotherapy.

Researchers from Chiba University, Japan, led by associate professor Rika Nakahashi-Ouchida and Ms Hiromi Mori of Chiba University Hospital, have developed an intranasal therapeutic option.

Unlike injectable vaccines, nasal vaccines trigger immunity at the mucosal surface — the protective lining of the upper airway.

This mucosal response can also protect distant sites, including the reproductive tract.

Building on earlier work showing nasal immunisation can elicit strong genital-tract responses against herpes simplex virus type 2, the team used cationic nano-sized hydrogel particles (cCHP nanogels) to deliver HPV antigens to nasal tissues.

These positively charged spheres adhere to the negatively charged nasal surface and slowly release antigens, which prompt an immune response.

Nakahashi-Ouchida said: “We have developed an intranasal therapeutic vaccine as a non-surgical alternative to conventional treatments that can compromise women’s quality of life.

“This novel nasal vaccine activates the mucosal homing pathways of lymphocytes, allowing it to trigger an immune response in the cervical mucosa, a site from the nasal administration.”

The formulation targets the E7 oncoprotein from HPV16, which inactivates pRb, a key tumour suppressor.

To strengthen responses, the researchers added cyclic-di-AMP, an adjuvant that boosts T-cell-mediated immunity so T cells can attack infected or cancerous cells.

The resulting cCHP-E7 + c-di-AMP showed what the researchers describe as strong anti-tumour activity in mice and macaques. In mouse models, it significantly slowed tumour growth versus controls.

In macaques, a nasal spray device (usable in humans) delivered four doses.

Vaccinated animals developed high levels of E7-specific helper and killer T cells producing molecules linked to tumour control; controls did not.

Immune activity was detected in cervical tissue, and E7-specific killer T cells persisted for at least four months, suggesting lasting defence.

According to the World Health Organization, cervical cancer caused an estimated 660,000 new cases and 350,000 deaths in 2022.

If proven safe and effective in humans, intranasal therapy could offer a non-invasive, fertility-preserving alternative to surgery for some patients.

The cCHP nanogel platform may also support nasal vaccines against other pathogens and wider clinical uses.

Nakahashi-Ouchida said: “Immunotherapies such as intranasal therapeutic vaccines may help establish a new category of non-invasive treatment.

“These approaches could be extended to recurrence prevention and chronic disease management, offering patients safer and more accessible options.”

Continue Reading

Hormonal health

Study reveals why women more likely to get severe long Covid

Published

on

New research has uncovered biological differences that explain why women with long Covid experience more severe and persistent symptoms than men.

Long Covid is diagnosed when neurological, respiratory or gastrointestinal symptoms persist for three months or more after SARS-CoV-2 infection.

Women are about three times more likely than men to develop it, but the biology behind this gap has been unclear.

The research from the University of Alberta suggests potential treatment targets that could help the 3.5 million Canadians who reported long Covid as of June 2023, according to Statistics Canada.

Principal investigator Shokrollah Elahi is an immunology professor in the Mike Petryk School of Dentistry.

The researcher said: “We are focusing on a subset of patients with the most devastating symptoms that are very similar to chronic fatigue syndrome.

“They didn’t have these symptoms prior to Covid and most had only mild Covid-19 disease, so they were not hospitalised.”

Elahi’s team ran blood and genetic tests on 78 patients with long Covid one year after their acute diagnosis, plus 62 controls who did not develop long Covid after infection.

By analysing immune cells, blood biomarkers (measurable signals of disease) and RNA sequencing (a method to read gene activity), the researchers identified a distinct immune signature in female versus male patients.

They found evidence of “gut leakiness” in female patients — when the intestinal barrier becomes more permeable and allows substances to pass into the bloodstream — including raised levels of intestinal fatty acid-binding protein, lipopolysaccharide and soluble CD14.

These signs of gut inflammation can trigger wider inflammation once in circulation.

“This suggests that probably at the earliest stage of disease when patients get acute SARS-CoV-2 infection, there is a tendency that the females’ guts are more prone to viral infection,” Elahi said.

The team also observed lower red blood cell production — anaemia — in female patients, suggesting elevated inflammatory factors in women with long Covid may impair blood formation.

In addition, they reported dysregulated sex hormones in long Covid: reduced testosterone in affected women, decreased oestrogen in male patients, and lower cortisol in both.

Women with lower testosterone had higher inflammatory markers. Because testosterone can help dampen inflammation, reduced levels may leave women more vulnerable to ongoing inflammatory responses. Lower testosterone was also linked to brain fog, depression, pain and fatigue.

The findings suggest hormone imbalance plays an important role in long Covid, particularly in how it affects women, Elahi said.

These results mirror some features of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which also disproportionately affects women.

For example, chronic inflammation is common to both, although anaemia is not typically associated with chronic fatigue.

The team’s conclusions are supported by another recent international study of more than 500 patients that also identified anaemia as a major biological driver of long Covid.

Elahi plans to validate the findings by testing potential treatments in mouse models of long Covid and is seeking funding for a clinical trial.

He proposes an individualised approach guided by test results that could include anaemia treatment, anti-inflammatory medicines and, in some cases, sex hormones.

He also aims to further explore similarities between neurological symptoms of long Covid and those seen in HIV.

Continue Reading

Wellness

Swimming, periods and finding freedom in my body

Published

on

By WUKA sports ambassador, Hannah Miley MBE 3x Olympian & Commonwealth champion

I started swimming when I was really young, I just loved being in the water.

The pool quickly became my second home, the place where I felt most like myself. I wasn’t a natural swimmer, but I loved to work hard, and racing gave me that outlet for my competitive side.

There was something about the rhythm of the strokes, the smell of chlorine, and the quiet hum beneath the surface that made me feel free.

I got my first period around age 12, and it was daunting. My body was changing, and I didn’t know what that meant for my swimming.

Wearing a swimsuit every day made me feel exposed, and I just assumed everything I was going through (heavy bleeding that lasted up to two weeks, cramps so bad they left me doubled over) was normal.

There were moments that really knocked my confidence: not realising my tampon string was visible, or climbing out of the pool to find blood running down my leg.

At competitions, I’d sometimes sit on my towel because I’d leaked through.

The heavy bleeding left me anaemic and constantly tired, but I kept pushing through. I wanted to swim at the highest level I could even if it meant battling my body every month.

Competitions & The Pill

I’ll never forget the 2004 Commonwealth Youth Games. My period started mid-competition, and during one race, the cramps hit hard.

Swimming through that pain was frustrating, all that training felt wasted. When I saw my GP back home, I was told the best way to “fix my period problems” was to go on the pill.

Those two words, fix and problems, shaped how I thought about my body for years.

At first, the pill seemed like the perfect solution. No more painful, unpredictable periods! I ran packets back to back to skip bleeds during competitions, thinking I was being smart.

What I didn’t realise was that the seven day break wasn’t a real period at all, it was a withdrawal bleed. I thought I was in control of my cycle, but I was actually masking it.

I didn’t understand how important my hormones were for health, recovery, and performance.

On the surface, everything looked fine. Beneath that, I was struggling. Under-fuelling, getting ill before big meets, and picking up constant shoulder and knee niggles.

But I didn’t connect any of it to my hormonal health. The pill blurred the picture, and for years, I lived in fear of my period returning at the “wrong” time.

Nothing compares to the emotion you feel when you make an Olympic team.

When I realised I had qualified for my first Olympics in 2008, it was surreal the culmination of years of early mornings, long sessions, and relentless dedication.

Standing on the pool deck with “Team GB” on my kit felt like stepping into a dream that little Hannah could only have imagined.

Racing around the world, representing Scotland and Team GB, was the greatest honour of my career.

Each competition taught me more about resilience, discipline, and the incredible things the human body can do when you push it to its limits.

I went on to swim at three Olympic Games, and while each one was different, they all shaped me not just as an athlete, but as a person learning to listen to and respect her body.

It wasn’t until 2020, during lockdown, that I finally came off the pill after more than 15 years. I was speaking to Dr Georgie Bruinvels when she asked a simple but powerful question:

“When was the last time you actually had a period?”

That question stopped me in my tracks. The answer? Not since before I started the pill as a teenager, over 15 years ago.

I learned that I should have taken longer breaks to let my hormones reset after five years.

It was probably mentioned when I first started but at 15 the chances of me remembering were going to be slim. I wished someone had reminded me.

For the first time, I began tuning into my body, tracking my cycle, adjusting my nutrition, and paying attention to the signals I’d ignored for so long. The difference was incredible.

My periods now last about five days, my cramps are mild and manageable, and I finally feel in sync with my body instead of fighting against it. And no little pill to remember to take each day.

The knowledge I have now would’ve been game changing for me as a young athlete.

Finding Freedom Again — This Time, on My Period

WUKA Sports Ambassador

Becoming a WUKA Sports Brand Ambassador felt like everything coming full circle.

To work with a company whose values aligned with my mission, supporting and empowering female athletes was incredible.

As an athlete, I only ever used tampons because I thought that was my only option.

But discovering products like period underwear and period swimwear has completely changed how I feel about my body and my period.

The first time I tried WUKA period pants, I couldn’t believe how comfortable they were. No rustling, no movement, and no fear of leaks. I actually forgot I was wearing them!

And their period swimwear? Game changer. No more worrying about climbing out of the pool and noticing blood running down my leg just confidence and freedom.

I can’t help but think how different my experience as a teenager could have been if products like this had existed then.

They would’ve given me comfort, reassurance, and a sense that my period wasn’t something to hide or fear.

That’s why I’m so passionate about opening up conversations around periods in sport.

For so many young athletes, missing training isn’t an option, but competing while bleeding can be stressful and distracting.

Period-proof swimwear can take away that anxiety — letting you focus on your performance, not your period.

What I’ve Learned

My journey has taught me that periods aren’t a “problem” to be fixed, they’re a natural, powerful part of who we are.

With the right knowledge, support, and tools, we can work with our bodies, not against them.

Period proof swimwear might seem like a small thing, but for a young swimmer, it can mean the world. It can mean the difference between fear and freedom, between shame and Confidence.

Periods are not the enemy of performance.

Ignoring them is.

Find out more about Wuka at wuka.co.uk 

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.